The Global Positive Airway Pressure Device Market Size is projected to grow at a CAGR of 8.40% during the forecast period from 2024 to 2030 | DelveInsight 

DelveInsight’s Positive Airway Pressure Device Market Insights Report 2030 provides the current and forecast market analysis, individual leading Positive Airway Pressure Device companies’ market shares, challenges, Positive Airway Pressure Device Market Drivers, barriers, trends, and key market Positive Airway Pressure Device companies in the market.

To read more about the latest highlights related to the Positive Airway Pressure Device Market @ https://www.delveinsight.com/report-store/positive-airway-pressure-device-market

Key Takeaways from the Positive Airway Pressure Device Market Report

• In July 2024, VARON entered the CPAP and BiPAP machine market with its feature-rich “Sunny Grand” series, comprising the 20A CPAP and the 25S BiPAP models, catering to a range of sleep apnea severities and user preferences. Strategic significance: Reflects continued new-entrant activity broadening the range of CPAP and BiPAP devices available to patients.
• In February 2024, ResMed launched a new bi-level sleep apnea device positioned as a CPAP alternative. Strategic significance: Expands treatment options for patients who may not tolerate or respond well to standard CPAP therapy.
• In August 2021, ResMed launched the AirSense 11 PAP Series, its next-generation PAP device for sleep apnea management, featuring Care-In and Personal Therapy Assistant capabilities among other features. Strategic significance: Advances ResMed’s core PAP platform with connected, patient-support features designed to improve therapy adherence.
• The Positive Airway Pressure Device market was valued at USD 1.92 billion in 2023 and is projected to reach USD 3.12 billion by 2030. Growth is driven by the increasing prevalence of sleep apnea, chronic obstructive pulmonary disease, and other respiratory disorders.
• The global Positive Airway Pressure Device market is growing at a CAGR of 8.40% during the forecast period from 2024 to 2030.
• The principal drivers are the rising burden of sleep apnea and chronic respiratory disorders; growing cases of neonatal respiratory distress syndrome; rising demand for non-invasive ventilation; increasing awareness and screening programs; and increased product development activity by key market players.
• The leading Positive Airway Pressure Device Companies include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, and 3B Medical Inc, among others.

To know more about why North America is leading the market growth in the Positive Airway Pressure Device Market, Get a snapshot @ https://www.delveinsight.com/report-store/positive-airway-pressure-device-market

Positive Airway Pressure Device Overview Positive airway pressure devices deliver a continuous or variable flow of air to keep a patient’s airway open and ensure adequate ventilation. The market spans Continuous Positive Airway Pressure (CPAP) devices, Auto-titrating Positive Airway Pressure (APAP) devices, Bi-level Positive Airway Pressure (BiPAP) devices, and other device types, used across adult and pediatric age groups in hospitals, clinics, and homecare settings. These devices are used to manage obstructive sleep apnea, chronic respiratory conditions such as COPD, and neonatal respiratory distress syndrome, a condition commonly seen in premature infants whose lungs are not fully developed.

Positive Airway Pressure Device Market Key Growth Drivers

• The increasing prevalence of obstructive sleep apnea and chronic respiratory conditions such as COPD is a core driver, with the Global Burden of Disease study estimating that approximately 1 in 20 people globally suffers from chronic respiratory disease.
• Rising rates of neonatal respiratory distress syndrome, common among premature infants whose lungs are not fully developed, are escalating demand for positive airway pressure support.
• Growing demand for non-invasive ventilation is a significant driver, as CPAP and BiPAP therapy offer comfort and reduce the risk of complications associated with invasive mechanical ventilation, and are increasingly used beyond sleep apnea in managing COPD, acute respiratory distress, and certain types of heart failure.
• Air pollution is contributing to rising demand, with the Global Burden of Disease reporting that particulate matter pollution was responsible for about 48% of COPD cases and around 34% of preterm births in 2021.
• Increased awareness and screening programs are facilitating earlier diagnosis and treatment, while continuous product development ensures devices meet evolving patient and healthcare needs.

Get a sneak peek at the Positive Airway Pressure Device Market Dynamics @ https://www.delveinsight.com/report-store/positive-airway-pressure-device-market

Positive Airway Pressure Device Market Segment Analysis 

The Positive Airway Pressure Device Market by Device Type (Continuous Positive Airway Pressure Devices, Auto-titrating Positive Airway Pressure Devices, Bi-level Positive Airway Pressure Devices, and Others), Age Group (Adults and Pediatrics), End-User (Hospitals, Clinics, and Homecare Settings), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

By device type, continuous positive airway pressure (CPAP) devices are expected to hold a significant share in 2023, given their position as the first line of positive airway pressure therapy, their simple design providing steady pressure for inhalation and exhalation, their lower cost relative to other device types, and their broad insurance coverage. Continuous innovation — including automatic pressure adjustments, integrated humidification, quieter operation, and mobile app connectivity for remote monitoring — is further supporting CPAP demand.

Which MedTech key players in the Positive Airway Pressure Device Market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/report-store/positive-airway-pressure-device-market

Positive Airway Pressure Device Market Region Analysis 

North America is expected to account for the highest proportion of the Positive Airway Pressure Device market in 2023, driven by the increasing prevalence of respiratory disease, growing government initiatives and awareness programs, rising preterm birth rates, and the presence of key market players engaged in mergers, acquisitions, and product launches. According to the CDC, 4.6% of US adults had been diagnosed with COPD, emphysema, or chronic bronchitis in 2022, and data from the State of Sleep Health in America indicate sleep apnea affects about 20% of US adults, with 90% of those cases undiagnosed. The National Council on Aging estimates approximately 39 million US adults have obstructive sleep apnea. Rising preterm birth rates are also propelling the market: CDC data show the preterm birth rate increased by 4% from 2020 to 2021, with the rate among Black women (14.6% in 2022) roughly 50% higher than among White women (9.4%) — a disparity that expands the population of preterm infants who may require respiratory support for neonatal respiratory distress syndrome. Continued product development, including 3B Medical’s February 2021 FDA approval of its third-generation Luna G3 Auto-BPAP device, is expected to further support regional market growth.

Positive Airway Pressure Device Companies 

ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Löwenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH, medicraft, Hebei Topson Medical Technology Ltd., Sefam, Löwenstein Medical Technology GmbH + Co. KG, and others.

Positive Airway Pressure Device Market Restraints 

The side effects associated with positive airway pressure devices, such as dry mouth, nasal congestion, or sinus infection, along with stringent regulatory concerns for product approval, may hinder growth of the Positive Airway Pressure Device market.

Interested in knowing the Positive Airway Pressure Device Market by 2030? Click to get a snapshot of the Positive Airway Pressure Device Market Trends- https://www.delveinsight.com/report-store/positive-airway-pressure-device-market

Scope of the Positive Airway Pressure Device Market Report

• Coverage- Global
• Forecast Period- 2024-2030
• Positive Airway Pressure Device Companies- ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, and others.
• Positive Airway Pressure Device Market Restraints and Regulatory Analysis
• Positive Airway Pressure Device Porter Five Forces Analysis and Market Assessment

Explore more information of the Positive Airway Pressure Device Market Insights @ https://www.delveinsight.com/report-store/positive-airway-pressure-device-market

Table of Contents

1. Positive Airway Pressure Device Market Report Introduction
2. Positive Airway Pressure Device Market Executive Summary
3. Positive Airway Pressure Device Competitive Landscape
4. Positive Airway Pressure Device Regulatory Analysis
5. Positive Airway Pressure Device Market Key Factors Analysis
6. Positive Airway Pressure Device Market Porter’s Five Forces Analysis
7. Positive Airway Pressure Device Market Assessment
8. Positive Airway Pressure Device Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us

Kanishk

info@delveinsight.com